跳至主要内容
临床试验/NCT06333834
NCT06333834已完成2 期

Assessment of the Efficacy of Anti-scorpion Venom Therapy in a Dose-response Manner, Following the Principles of Rational Drug Use in Patients With Scorpionism: a Non-inferiority, Randomized, Double-blind, Controlled Clinical Trial

Selene Guadalupe Huerta Olvera1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2024年6月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
56
试验地点
1
主要终点
Time to resolution of signs and symptoms

研究概览

简要总结

The clinical study aims to compare the effectiveness of applying two different regimens of scorpion antivenom therapy. In the first regimen (control), the medication is administered to all patients, and depending on the severity of the condition, the dosage varies. In the experimental regimen, an identical dose of scorpion antivenom is administered to patients exhibiting signs and symptoms of scorpion sting intoxication, in addition to pain and other symptoms at the sting site. The primary response variable is the time taken for signs and symptoms to resolve, but differences in complications, adverse effects, venom and antivenom concentration in the blood, and the need for other therapeutic measures are also evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

A pharmacist will be responsible for randomizing the patients and preparing the study medication in a blinded manner, so that the treatment is administered by the physician without the care provider or the participant being able to identify it. The pharmacist will keep the randomization results in a sealed envelope that will be opened at the end of the study.

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals aged 18 or older presenting with a diagnosis of scorpionism to the emergency department.
  • Treated solely with paracetamol, scorpion antivenom, saline solution, and local ice application.
  • Any gender.
  • Less than two hours elapsed since scorpion sting.
  • Willing to participate in the study through written informed consent.

排除标准

  • Allergies or contraindications to any of the study medications.
  • Uncertainty regarding scorpion sting.
  • Previous treatment by another physician.
  • Intramuscular administration of scorpion antivenom due to urgent clinical conditions.
  • Decision not to provide informed consent.
  • Any limitations hindering the proper understanding of study participation.

研究组 & 干预措施

Traditional scorpion antivenom regimen

Active Comparator

Active/placebo comparator

干预措施: Traditional scorpion antivenom regimen (Drug)

Serial dose of scorpion antivenom regimen

Experimental

干预措施: Serial dose of scorpion antivenom regimen (Drug)

结局指标

主要结局

Time to resolution of signs and symptoms

时间窗: two and a half to five hours

Time to resolution of signs and symptoms from admission and from the estimated time of the sting

Serum venom concentration

时间窗: two and a half to five hours

Serum venom concentration upon patient arrival, after administration of antivenom, and upon reporting the absence of signs of intoxication

次要结局

  • Mortality(two and a half to five hours)
  • Length of intrahospital stay(two and a half to five hours)
  • Serum antivenom concentration(two and a half to five hours)

研究者

发起方
Selene Guadalupe Huerta Olvera
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Selene Guadalupe Huerta Olvera

Professor and researcher

University of Guadalajara

研究点 (1)

Loading locations...

相似试验